Keyman risk
Also written Key man risk · Keyman dependency
The risk that a company depends so heavily on one or a few individuals that a change at the top can derail its decision making.
In plain language
Some companies are really one person. The founder makes the decisions, holds the relationships and carries the strategy in their head.
While that person is there, it can work very well. Decisions are fast and consistent.
The problem is what happens if they leave. If nobody else was making decisions, nobody else can. That exposure is keyman risk.
The workbook treats it as something an analyst can actually test for, and it points at 2 things: how far decision making is spread through the organisation, and whether there is a succession plan.
How it works
Where it appears. Section 7.6.1 is a checklist for evaluating management competency, and keyman risk arrives in item (i): "Is there sufficient delegation in the decision-making process? If the decision-making process is well delegated and is fairly broad based, it can ensure continuity even when there is churn in top management. On the other hand, if the decision making is highly concentrated then it creates keyman risk as churn in top management can derail the decision-making process."
So the workbook does not define keyman risk as a personality question. It defines it structurally: concentrated decision making creates it, delegated decision making prevents it.
The second test. Item (j) follows immediately: "Does the company have a succession plan for its top management? In line with the previous point, a proper succession management plan ensures continuity even if there is a churn in top management. Lack of succession planning can create trouble if the current management has to be replaced for any reason whatsoever."
Note the phrase "for any reason whatsoever." The workbook is not only thinking about death or illness. A resignation, a dismissal or a regulatory disqualification produces the same gap.
How it connects to the rest of chapter 7. Section 7.7 (Risks in the Business) frames the analyst's standing question as "What could go wrong in the business," and warns about promoters who claim nothing could: those "fall into the category of people who don't know that they don't know," and "these types of promoters need to be avoided." Keyman risk is one of the specific answers to that standing question, and a promoter unwilling to discuss succession is displaying the attitude 7.7 warns about.
On figures. The workbook attaches no number to keyman risk — no concentration measure, no threshold, no discount to apply in a valuation. Both tests, delegation and succession, are qualitative checklist questions. Do not expect, or invent, a percentage here.
A worked example
Illustrative. Two mid-sized companies of the same size in the same industry, each with revenue of Rs 1,800 crore.
| Company A | Company B | |
|---|---|---|
| Decisions above Rs 5 crore | Taken by the founder alone | Delegated to 4 business heads |
| Business heads with profit and loss responsibility | 0 | 4 |
| Named successor for the MD | None | Deputy MD, in role 3 years |
| Top 20 customer relationships | Held personally by the founder | Held by named account teams |
On the workbook's 2 tests, Company A has keyman risk and Company B has largely engineered it away.
Now apply the shock. The founder of Company A resigns with 1 month's notice. Pricing approvals stall, 2 large customers ask who they now deal with, and the board has to run a 9-month external search. The same event at Company B moves the Deputy MD up and nothing else changes.
An analyst cannot put a rupee value on this from the workbook, which gives no figure. What the analyst can do is exactly what section 7.6.1 asks: record that Company A's decision making is highly concentrated and its succession plan absent, and carry that into the risk section of the research report rather than into the earnings model.
Why NISM asks about it
Section 7.6.1 (Evaluating management competency) is a 10-item checklist and keyman risk is named in item (i), with succession planning in item (j). Section 7.7 (Risks in the Business) is the frame around it.
The question is usually a scenario: a company is described with concentrated decision making or no succession plan, and you are asked which risk the analyst should flag. The complementary version asks what mitigates keyman risk, where the workbook's 2 answers are delegation and a succession plan. Note the vocabulary trap — the workbook writes "keyman risk," and it is not the same thing as key man insurance, which this paper does not teach.
Common exam traps
- The workbook gives no figure for keyman risk. Delegation and succession are qualitative checks. A question offering a concentration percentage is not drawn from this text.
- Keyman risk is created by concentrated decision making, not merely by having a famous founder. A charismatic chief executive who has delegated well does not create it.
- The 2 mitigants are delegation and succession planning, and the workbook links them expressly — item (j) opens "in line with the previous point."
- "For any reason whatsoever" includes resignation and dismissal, not only death or illness.
- Keyman risk is not agency risk. Agency risk is management acting in its own interest rather than shareholders'. Keyman risk is the company being unable to function without a particular person. A single dominant individual can create both, but they are different failures.
- Do not confuse it with key man insurance, a life insurance product. Chapter 7 is about assessing the risk, not insuring it.
- This is not XIX-B's key-person risk. That page is about an AIF losing its investment manager, which disrupts the fund's own decisions, redemptions and compliance. This page is about a company you are researching depending on one or two people. Same idea, different subject: there the risk is inside the fund, here it is inside the investee.
Where this is taught
Free preparation for NISM Series XVRelated terms
- Agency riskThe risk that a company's management, who control day-to-day decisions, pursue their own interests rather than those of the shareholders who actually own the business.
- Corporate governanceThe rules, processes and procedures followed in running a company, judged by an analyst against a checklist of board, audit and related-party tests rather than by reputation.
- MoatThe durable competitive advantage that lets a company keep earning high returns while competitors try and fail to take its business.
- Nomination committeeThe board committee that appoints independent directors, which the workbook says should ideally consist exclusively of independent directors so that company executives have no role in the appointment.
- Related party transactionA deal between a company and a party connected to its controllers — promoters, their relatives, group firms. Watched because it can enrich the promoter group at minority shareholders' cost.
- Succession planningPlanning to keep a family business viable and pass control of it to the next generation while its owner is still alive — a distinct exercise from estate planning, which deals with an individual's personal assets.
- Key-Person RiskThe risk that the death, incapacity or unavailability of the investment manager seriously disrupts a Category III AIF — its investment decisions, redemptions, compliance and trade execution.
- Keyman insuranceA life insurance policy a company buys on the life of a key executive, paying the premiums and taking the benefit itself — and the one life policy whose proceeds are not exempt under section 10(10D).